Saroten


European Medicines Agency - Human medicines

7.13.2018 writer Emma Carey
Saroten
European Medicines Agency - Human medicines

On 23 February 2017, the European Medicines Agency completed a review of Saroten. The Agency's Committee for Medicinal Products for Human Use (CHMP).

The CHMP agreed that Saroten and associated names could be used in adults for:

For the treatment of bedwetting the dose is given an hour to an hour-and-a-half before bedtime and a course of treatment should last for a maximum of 3 months. The medicine should not be given to children to treat depression or pain. 4.3 Contra-indications.

It contains the active substance amitriptyline.

Saroten

6.12.2018 writer Emma Adderiy
Saroten

Saroten is a medicine available in a number of countries worldwide. A list of US medications equivalent to Saroten is available on the website.

Important Notice: The international database is in BETA release. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. This means it is still under development and may contain inaccuracies. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Saroten may be available in the countries listed below.

To view content sources and attributions, please refer to our editorial policy. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Data sources include Micromedex (updated Sep 4th, 2018), Cerner Multum (updated Sep 4th, 2018), Wolters Kluwer (updated Sep 3rd, 2018) and others.

Amitriptyline hydrochloride (a derivative of Amitriptyline) is reported as an ingredient of Saroten in the following countries:

The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices.

We comply with the HONcode standard for trustworthy health information - verify here.

Subscribe to receive notifications whenever new articles are published.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Medical Disclaimer.

A clinical trial comparing sustained release amitryptyline (Saroten

5.11.2018 writer Ava Jacobson
Saroten

A clinical trial comparing sustained release amitryptyline (Saroten Retard) and conventional amitriptyline tablets (Saroten) in endogenously depressed patients.

Warning: The NCBI web site requires JavaScript to function. more.

No correlation could be shown between the clinical effects and the serum concentrations of amitriptyline and nortriptyline. and 9 p.m.). No difference was found between the two preparations as regards either clinical effect or side effects. The clinical effect of a sustained release preparation of amitriptyline has been compared with that of conventional amitriptyline tablets in a double-blind cross-over study with 24 patients suffering from endogenous depression. The sustained release preparation was given in a single evening dose (9 p.m.) of two thirds the total daily dose of conventional tablets, which was given in a three times-a-day regimen (8 a.m., 12 a.m. Serum concentrations of amitriptyline and its active metabolite, nortriptyline, were determined.

Generate a file for use with external citation management software.

National Center for Biotechnology Information, U.S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA.

Saroten retard 25 in mild depression and nondepressive anxiety

4.10.2018 writer Jasmine Larkins
Saroten

Med Welt. 1972 Oct 7;23(41):1436-8. [Saroten retard 25 in mild depression and nondepressive anxiety]. [Article in German]. Braasch F. PMID: 5087195; [Indexed.

Warning: The NCBI web site requires JavaScript to function. more.

Generate a file for use with external citation management software.

National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA. National Center for Biotechnology Information, U.S.

Saroten Retard

11.17.2018 writer Ava Jacobson
Saroten

Saroten Retard is a medicine available in a number of countries worldwide. A list of US medications equivalent to Saroten Retard is available on the.

It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices.

Saroten Retard may be available in the countries listed below.

Amitriptyline hydrochloride (a derivative of Amitriptyline) is reported as an ingredient of Saroten Retard in the following countries:

We comply with the HONcode standard for trustworthy health information - verify here.

Amitriptyline is reported as an ingredient of Saroten Retard in the following countries:

provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex (updated Sep 4th, 2018), Cerner Multum (updated Sep 4th, 2018), Wolters Kluwer (updated Sep 3rd, 2018) and others. To view content sources and attributions, please refer to our editorial policy.

Subscribe to receive notifications whenever new articles are published.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Medical Disclaimer.